Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New results data appear on the page, with updated outcome measures and study dates. This expands the core content about the trial's efficacy, safety outcomes, and overall status.
    Difference
    0.3%
    Check dated 2025-10-27T20:59:00.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    2%
    Check dated 2025-10-06T08:12:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page updates the version from v3.0.2 to v3.1.0, changing the revision identifier. Overall meaning remains the same with an upgraded version tag.
    Difference
    0.1%
    Check dated 2025-09-29T04:43:00.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    - Version bumped from v3.0.1 to v3.0.2; no substantive content changes. - The 'Back to Top' element was removed, indicating a minor UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-14T22:12:31.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T19:27:39.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has added significant information regarding new therapeutic agents and their related topics, while also updating the facility name and location details. Notably, the previous version's references to certain drugs and locations have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:26:33.000Z thumbnail image

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.